Drug Profile
Research programme: drug discovery - TPP/University of Aberdeen
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of Aberdeen
- Developer TPP Global Development; University of Aberdeen
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Cancer
- No development reported Immunological disorders; Inflammation; Neurological disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Immunological-disorders in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neurological-disorders in United Kingdom